ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Clinical Trial of Proxalutamide's Trial of Hospitalized Covid-19 Patients Was Approved in Brazil
January 29, 2021Kintor Pharmaceutical Limited is pleased to announce that the clinical trial of Proxalutamide's treatment of hospitalized COVID-19 patients was approved by the Institutional Review Board of Brazil. -
Kintor's Proxalutamide (GT0918) COVID-19 Clinical Trial Shows Positive Preliminary Results in Treatment of Female Patients
January 11, 2021Kintor Pharmaceutical Limited is pleased to update the preliminary analysis of the clinical trial of Proxalutamide for the treatment of COVID-19 patients.
Pharma Sources Insight January 2025
